IMO, if Bayer acquires MON, the objections to glyphosate in the EU will quickly diminish.
One thing that makes me thing it will happen is this - Cramer says it's a no-go.
Investors are dubious of chances of deal ultimately going through.
If you think it will, here's a chance for you to make some easy money.
The risk is, the deal doesn't happen, and MON bounces back down to 95.
I guess you could call that an increase. 2.17% over May 2015. Smallest increase in a long time.
Methinks its up because of all the downgrades.